Bellinzona, Switzerland

Francesco Bertoni

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Francesco Bertoni: Innovator in Pharmaceutical Combinations

Introduction

Francesco Bertoni is a notable inventor based in Bellinzona, Switzerland. He has made significant contributions to the fields of immunology and molecular biology, holding a total of six patents. His work primarily focuses on developing innovative pharmaceutical combinations aimed at treating various diseases, including cancers.

Latest Patents

One of Bertoni's latest patents involves pharmaceutical combinations comprising an anti-LY75 antibody. This patent relates to the development of antibodies directed against LY75, combined with a second anti-cancer entity. The disclosure includes methods for preparing these antibody combinations and their application in treating diseases mediated by LY75 expression or activity. Another significant patent details compounds with enhanced anti-tumor effects. These new anti-proliferative agents demonstrate remarkable in-vivo anti-tumor activities, particularly against lymphomas of different origins.

Career Highlights

Throughout his career, Bertoni has worked with various companies, including Oncoethix GmbH and Berlin-Chemie AG. His innovative research has positioned him as a key figure in the pharmaceutical industry, particularly in the development of cancer therapies.

Collaborations

Bertoni has collaborated with notable professionals in his field, including Monica Binaschi and Mario Bigioni. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Francesco Bertoni's contributions to pharmaceutical innovations highlight his role as a leading inventor in the field. His work continues to impact the development of effective treatments for cancer and other diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…